(Q28195765)

https://api.crossref.org/works/10.1016/S0197-4580(02)00188-4

27 December 2023

author name string

C. Jonker

series ordinal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714115

27 December 2023

H. C. Comijs

series ordinal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714115

27 December 2023

J. H. Smit

series ordinal

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714115

27 December 2023

language of work or name

English

0 references

publication date

2003

1 reference

PubMed

July 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714115

full work available at URL

27 December 2023

https://api.elsevier.com/content/article/PII:S0197458002001884?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0197-4580(02)00188-4

https://api.elsevier.com/content/article/PII:S0197458002001884?httpAccept=text/plain

27 December 2023

1 reference

DOI

https://api.crossref.org/works/10.1016/S0197-4580(02)00188-4

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

27 December 2023

published in

Neurobiology of Aging

0 references

volume

24

0 references

issue

4

0 references

page(s)

583-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Major and minor depression in later life: a study of prevalence and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Aging and speed of behavior: possible consequences for psychological functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Anti-inflammatory drugs protect against Alzheimer disease at low doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Platelets are the primary source of amyloid beta-peptide in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

1 reference

7 January 2021

Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Aspirin, anti-inflammatory drugs and risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

NSAIDs and incident Alzheimer’s disease. the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Clinical significance: A statistical approach to defining meaningful change in psychotherapy research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Protective effect of chronic NSAID use on cognitive decline in older persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Aspirin use and cognitive function in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Contribution of cognitive abilities to performance and improvement on a substitution coding task

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Clinically significant change: Jacobson and Truax (1991) revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900188-4

7 January 2021

Identifiers

DOI

0 references